Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based Chemotherapy | Zendy

Xingqin Zhou | Zendy; Yazhou Chang | Zendy; Jing Qian | Zendy; Chaoyan Shen | Zendy; Jie Han | Zendy; Hongyu Zhao | Zendy; Renan Chang | Zendy

Open Access

Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based Chemotherapy

Author(s) -

Xingqin Zhou,

Yazhou Chang,

Jing Qian,

Chaoyan Shen,

Jie Han,

Hongyu Zhao,

Renan Chang

Publication year - 2021

Publication title -

medical science monitor

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.636

H-Index - 85

eISSN - 1643-3750

pISSN - 1234-1010

DOI - 10.12659/msm.929474

Subject(s) - medicine , colorectal cancer , fluorouracil , chemotherapy , toxicity , therapeutic drug monitoring , adverse effect , dosing , gastroenterology , area under the curve , pharmacokinetics , therapeutic index , oncology , cancer , drug , pharmacology

Corresponding Author: Renan Chang, e-mail: mixu126@126.com Source of support: The research and manuscript preparation were funded by Jiangsu Provincial Government Scholarship Fund Project (Su Jiao Wai Han [2019] No. 43); Wu Jieping Medical Fund Project (No. 320.6750.2020-18-1); Nantong Science and Technology Planning Project (JCZ19092); Nantong Municipal Health Commission Project (MB2019054); Nantong Science and Technology Project (JC2020056)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research